ライフサイエンスコーパス: recombinant human growth hormone

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 not to receive daily intramuscular doses of recombinant human growth hormone (0.15 mg rhGH/kg/day).

2 nts were randomly assigned to receive either recombinant human growth hormone, 0.1 mg/kg of body weig

3 sequence coverage of a therapeutic protein, recombinant human growth hormone, and in detection of si

4 tween protein molecules within aggregates of recombinant human growth hormone are responsible for the

5 In recent years, the use of recombinant human growth hormone as a therapeutic modali

6 after renal transplant, early institution of recombinant human growth hormone can promote growth.

7 Recombinant human growth hormone (GH) improves in vivo c

8 For some, like Turner syndrome, recombinant human growth hormone has become the standard

9 Recombinant human growth hormone has been employed to am

10 Recombinant human growth hormone (hGH) therapy in childr

11 The efficacy of recombinant human growth hormone in the treatment of gro

12 minimum, administration of anabolic agents, recombinant human growth hormone, insulin, oxandrolone,

13 Although recombinant human growth hormone is commonly used to tre

14 Treatment with recombinant human growth hormone likely increases the IG

15 he characterization of disulfide linkages of recombinant human growth hormone (Nutropin), a therapeut

16 nt of metabolic bone disease, and the use of recombinant human growth hormone provide some hope for c

17 Nevertheless, the use of recombinant human growth hormone remains limited in pati

18 For others, the ultimate benefit of recombinant human growth hormone remains to be determine

19 Benefits of recombinant human growth hormone (rhGH) alone or combine

20 s the current evidence concerning the use of recombinant human growth hormone (rhGH) as a potential t

21 Pharmacologic doses of recombinant human growth hormone (rhGH) constitute anoth

22 level I trauma center who were treated with recombinant human growth hormone (rhGH) for > or =7 days

23 pared and shown to promote the absorption of recombinant human growth hormone (rhGH) from the gastroi

24 Recombinant human growth hormone (rHGH) has been shown t

25 The structural stability of recombinant human growth hormone (rhGH) has been studied

26 l reference method for the quantification of recombinant human growth hormone (rhGH) in serum has bee

27 Recombinant human growth hormone (rhGH) reduces visceral

28 Recombinant human growth hormone (rhGH) therapy is used

29 Administration of recombinant human growth hormone (rhGH) to critically il

30 sively burned children during treatment with recombinant human growth hormone (rhGH), and to ascertai

31 We have previously shown that low-dose recombinant human growth hormone (rhGH), given to childr

32 he use of the exogenous hormones estrogen or recombinant human growth hormone (rhGH).

33 During the last decade, we have used recombinant human growth hormone (rhGH; 0.2 mg/kg/day s.

34 Somatropin (i.e., recombinant human growth hormone, rhGH) modified with th

35 ren with JRA and growth retardation received recombinant human growth hormone (rHuGH) for 1 year.

36 Low-dose recombinant human growth hormone successfully abates mus

37 Recombinant human growth hormone therapy of children wit

38 is important to recognize that the impact of recombinant human growth hormone therapy on adult height

39 Deciding when to pursue recombinant human growth hormone therapy to increase adu

40 kbar to suspensions containing aggregates of recombinant human growth hormone (up to 8.7 mg/ml) and 0

41 types of insoluble, non-native aggregates of recombinant human growth hormone were formed by agitatio

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。